undefined undefined
NaN.000
NaN.00%
Atea Pharmaceuticals (NASDAQ:AVIR) reported its Q4 earnings results on Wednesda...
02-29 05:35
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion.
02-28 19:24
Atea Pharmaceuticals Inc (NASDAQ: AVIR) reported initial data from the first 52 patients in the lead-in cohort of its Phase 2 combination eight-week study of bemnifosbuvir and ruzasvir (RZR) for
01-10 02:33
BOSTON, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: A...
01-03 08:00
今冬初雪已至,寒意加剧。Biotech早已开始了寒冬蛰伏,big pharma则在伺机“捡漏”。因为后者通常手握巨额现金,且都有着强烈的管线补充意愿。 今年以来...
2023-12-11 20:18
Atea Pharmaceuticals (NASDAQ:AVIR) is set to give its latest quarterly earnings...
2023-11-08 02:01
Vineyards need many things to go right to grow grapes. They need cooperative we...
2023-10-23 23:23
Upgrades For Roblox Corp (NYSE:RBLX), Wedbush upgraded the previous rating of N...
2023-08-10 23:00
JP Morgan analyst Eric Joseph downgrades Atea Pharmaceuticals (NASDAQ:AVIR) from Neutral to Underweight.
2023-08-10 17:28
What is the target price for Atea Pharmaceuticals (AVIR)?The latest price targe...
2023-08-10 05:28